startup founder & entrepreneur; striving to improve lives of children through improving the standard of care to focus on root causes and actionable solutions
@ReachRuthanne@SpectrumDads Leucovorin has been show to effective in children with autism that have confirmed language impairment (which is a core diagnostic feature of ASD). Children that are most likely to respond have functional metabolic defects, mainly in folate autoantibodies and/or oxidative stress
@zemacplayer@SpectrumDads FRAA is positive in 70-75% of children with ASD and low GSH/GSSG along with poor methylation are found in over 95% of children with ASD compared to control children. It’s worth a therapeutic trial given the safety profile and high prevalence of biomarker findings
This autism dad just realized that his daughter has a superpower:
She remembers EVERYTHING.
“Our conversations.”
“Our attitude toward her disabilities.”
“Even if they’re non-speaking, non-verbal … building up self-confidence and self-esteem is so, so important.”
This video will absolutely melt your heart.
This father has a daughter with autism.
Watch as he gets her to sing “Take Me Out to the Ball Game” along with him.
“I believe that at least 1% of the reason why her spoken language continues to improve is activities like this.”
BREAKING:
A new CNN report revealed that a nationwide supply crunch has left children with autism struggling to find leucovorin.
Today, we are delivering a new option for families navigating ASD.
We just officially launched a new telehealth platform in all 50 states.
Our initial clinical focus is on a key biological mechanism:
The cerebral folate pathway1.
Our platform supports telehealth access to licensed providers for families exploring leucovorin, a compounded formulation of vitamin B9 (folate), through an off-label prescription in ASD, which research has shown improves language and communication in children with ASD2,3.
And it arrives at a critical moment.
Millions of families are seeking clearer, more coordinated care.
John Slattery, our CEO and Co-Founder, announced:
“The timing couldn’t be better to launch a 50-state telehealth solution to provide guidance and clarity.”
“Our kids deserve better.”
“Meadow was built to deliver exactly that.”
We’re streamlining specialist access.
Securing reliable medication supply.
And saving families money.
Access to our telehealth platform starts at just $199/month.
Our compounded medication is dye-free, gluten-free, casein-free, and delivered within seven business days.
Find out everything you need to know about our new telehealth platform using the link in the thread below:🧵
This content is for informational, educational, and entertainment purposes only; it is not medical advice, diagnosis, or treatment. This content may include discussion of off-label, non-FDA-approved uses of Leucovorin (folinic acid). Cited clinical data does not guarantee results. Meadow Biosciences provides telehealth access to licensed providers, who make independent decisions. Consult a healthcare professional before making healthcare changes; seek emergency care if needed.
Compounded medications are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety, efficacy, or quality. These products are prepared to meet the unique needs of an individual patient based on a valid prescription from a licensed prescriber.
References
1. https://t.co/BXJ26KwHMq
2. https://t.co/1ciUhex5mI
3. https://t.co/mzGAOODstG
@austinxwalker We’re building a metabolic health operating system that continuously updates pathway dysregulation probabilities and treatment response predictions using longitudinal real-world patient outcome data through a 50-state telehealth platform. First proof of concept is autism
NEW:
Register now for our FREE February 7 event: A New Standard for Autism Care
YOU are invited to join leading clinicians and advocates for an expert-led conversation on leucovorin, apraxia, and all the key issues families ask about most.
Register now for FREE with the link in our bio!
Bookmark this post to save the date and tag a friend below.
We’ll see you soon!
@drdanajohnson@drkurtwoeller@KSelbyGonzalez
@stkirsch@SenWarren Happy to connect and share our research into the biological basis of ASD. Feel free to DM and we can schedule time to talk. I’ve been involved in investigating the biological basis of ASD for 15+ years
@stkirsch@stkirsch I’ve been investigating the biological basis of ASD for over 15 years and have developed a validated laboratory assay to stabilize redox metabolic pathways, mitochondrial biomarkers, and cellular methylation capacity as a tool to assess asd risk and monitor progression
@AVPac_US See our recent @TACAfoundation blog and our support of RFK Jr and the Administration's commitment to getting to the bottom of what's driving the #ASDepidemic#NOTanEpidemicDenier
https://t.co/nxTIrvXhie
While there's significant public opinion and disagreements on RFK Jr's statements related to ASD, we stand by his commitment to advancing our understanding of ASD & to expand research into environmental risk factors. @TACAfoundation@AutismEnergetic
https://t.co/nxTIrvXhie
WSJ: What’s Behind the Rise in Autism? https://t.co/q0WJe8n3jx states: Autism rates are not really going up
We say: While skeptics are free to believe autism rates are not increasing, the burden of proof now lies with those who refute the mountain of data stating otherwise